Eastland gets nod for first trial of malaria treatment

Perth-based Eastland Medical Systems Ltd says it is on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi-dose Phase 1 clinical trial in February, after its pharmaceutical division received regulatory approvals i


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/19

1 year TSR5 year TSR
46thBARD1 Life Sciences71%-3%
617thAurora Labs-51%
675thCreso Pharma-58%
713thMGC Pharmaceuticals-64%32%
731stSUDA Pharmaceuticals-66%-39%
726 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$42k Sold
$24k Issued
$61k Issued
Total value as at the date of the transaction
Source: Morningstar


176th↓SUDA Pharmaceuticals$488k
185th↓MGC Pharmaceuticals$403k
186th↑BARD1 Life Sciences$357k
188th-Aurora Labs$330k
189th↑Creso Pharma$244k
231 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer